美国血液透析机构感染预防与控制实践的变化:2015年与2021年比较
该研究比较了2015年和2021年美国门诊血液透析机构报告的感染预防与控制实践。2021年有7400家机构完成调查,涵盖503530例透析患者。与2015年相比,若干推荐的导管护理实践使用率变化超过5个百分点,如氯己定醇皮肤消毒使用率90.8%(+5.9个百分点),酒精消毒导管 hubs 使用率84.3%(+9.9个百分点)。
要点
- 2021年与2015年相比,多项推荐导管护理实践使用率变化超过5个百分点。
- 氯己定醇用于皮肤消毒使用率达90.8%,酒精用于导管 hubs 消毒达84.3%。
- 2021年49.3%的机构使用氯己定浸渍导管帽。
核心结论
- 推荐感染预防实践的使用率增加及氯己定浸渍导管帽的引入可能有助于降低血液透析患者血流感染率。
- 仍需持续努力增加CDC推荐导管出口处护理实践的采纳并维持高使用率实践。
研究设计与样本
- 分析2015年和2021年美国门诊血液透析机构完成的NHSN门诊透析实践调查中感染预防与控制实践数据。
- 2021年有7400家机构完成调查,涵盖503530例透析患者。
主要发现
- 2021年与2015年相比,>5个百分点的变化见于多项推荐导管护理实践,如出口处护理(氯己定醇皮肤消毒使用率90.8%,+5.9个百分点;抗菌软膏或氯己定浸渍敷料使用率29.0%,+6.4个百分点)和导管 hubs 护理(酒精用于 hubs 消毒使用率84.3%,+9.9个百分点)。
- 2021年49.3%的机构使用氯己定浸渍导管帽。
关键数值与推荐
- 大于5个百分点的差异被预先选定为可能提示有意义的变化。
- 2021年氯己定醇用于皮肤消毒使用率为90.8%,较2015年增加5.9个百分点。
- 2021年抗菌软膏或氯己定浸渍敷料使用率为29.0%,较2015年增加6.4个百分点。
- 2021年酒精用于导管 hubs 消毒使用率为84.3%,较2015年增加9.9个百分点。
- 2021年49.3%的机构使用氯己定浸渍导管帽。
临床怎么用
- 临床应继续采纳CDC推荐的导管出口处护理实践,并维持高使用率的感染预防措施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: From 2014 through 2019, bloodstream infection (BSI) rates among US hemodialysis patients decreased by 40%. Several national efforts to address the burden of BSIs among hemodialysis patients were introduced spanning 2015 through 2019. We aimed to compare facility-reported infection prevention and control (IPC) practices in 2015 and 2021, to identify changes in practices nationally. METHODS: Outpatient hemodialysis facilities complete the National Healthcare Safety Network (NHSN) Outpatient Dialysis Practices Survey annually. Data from the Practices Survey pertaining to IPC practices were analyzed for 2015 and 2021. Counts, percentages, and medians with interquartile ranges were calculated, as appropriate. Percentage differences or points (% points) were calculated to compare specific variables from 2015 and 2021. Greater than 5% point difference was a priori selected as possibly suggesting a meaningful change. RESULTS: In 2021, 7400 facilities completed the survey, comprising 503,530 dialysis patients. In 2021 compared with 2015, >5% point change was observed for several recommended catheter care practices such as exit site care (use of chlorhexidine with alcohol for skin antisepsis [90.8% uptake, +5.9% points] and antimicrobial ointment or chlorhexidine-impregnated dressing [29.0%, +6.4% points]), and catheter hub care (alcohol for hub antisepsis [84.3%, +9.9% points]). In 2021, 49.3% of facilities used chlorhexidine-impregnated catheter caps. DISCUSSION: Increased uptake of recommended IPC practices, and introduction of chlorhexidine-impregnated catheter caps may have contributed to decreased BSI rates among hemodialysis patients. Continued efforts are needed to increase adoption of Centers for Disease Control and Prevention (CDC)-recommended catheter exit site care practices and ensure maintenance of IPC practices with high uptake.
引用
- Apata IW, Bardossy AC, Rodriguez A, et al. Infection Prevention and Control Practices Among United States Hemodialysis Facilities. Kidney Int Rep. 2026. PMID: 42564803. doi:10.1016/j.ekir.2026.106677
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。